Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Cerebras Systems $6.4 billion IPO
We advised the underwriters on the IPO
Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction
BBVA $2.25 billion contingent convertible securities and senior notes offerings
We advised BBVA on its offerings
Purdue Pharma completes chapter 11 restructuring
We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
Bolivia $1 billion sovereign bond issuance
We advised Bolivia on the offering
First Eagle Holdings $575 million debut senior secured notes offering
We advised the initial purchasers on the high-yield notes offering
Antares Capital closes $8.5 billion Senior Loan Fund III
We advised Antares Capital on the formation, fundraise and related matters for Antares SLF III
Las Vegas Sands $1 billion notes offering
We advised the underwriters on the offering
J&F $485 million exchange offer and consent solicitation
We advised the dealer managers and solicitation agents on the exchange offer
METiS TechBio HK$2.43 billion IPO
We advised METiS TechBio on its IPO and HKEX listing